FDA Warning Letter — Supreme Rejuvenation
The FDA took a Warning Letter action against Supreme Rejuvenation on May 5, 2025 (Houston, TX). The action was issued by CBER and concerns biologics products.
Action Details
- Facility
- Supreme Rejuvenation
- Date
- May 5, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Center
- CBER
- Location
- Houston, TX (United States)